多发性硬化症中皮质类固醇诱导的低免疫球蛋白水平 - 一个混因素
Mickael Bonnan1, Henri Courtade2, Stéphane Debeugny3
1Service de neurologie, Hôpital Delafontaine, Saint-Denis 93200, France.
Multiple sclerosis and related disorders
|September 29, 2023
概括
高剂量的皮质类固醇 (CS) 在多发性硬化症 (MS) 患者中显著降低免疫球蛋白 (Ig) 水平,即使使用疾病修饰药物 (DMD) 治疗. 这种CS对Ig水平的影响是MS研究中需要考虑的关键因素.
科学领域:
- 免疫学 免疫学 免疫学
- 神经学 神经学
- 药理学 药理学是指药理学的学科.
背景情况:
- 免疫球蛋白 (Ig) 水平可以随着用于多发性硬化症 (MS) 的免疫调节药物而改变.
- 高剂量皮质类固醇 (CS) 对MS患者Ig水平的影响尚不清楚.
研究的目的:
- 研究疾病修饰药物 (DMD) 和皮质类固醇 (CS) 对MS患者免疫球蛋白水平的影响.
主要方法:
- 一项回顾性研究分析了7年来304名多发性硬化症患者的1204个样本.
- 在单个多发性硬化中心对Ig水平的变化进行了检查,与CS的管理有关.
主要成果:
- 在24个月内,CS输液与MS患者的IgG水平显著降低有关.
- 在接受DMD治疗的患者中观察到较低的IgG水平,这些患者也接受了CS.
- CS与DMD相互作用,降低IgM水平.
结论:
- 在MS患者的DMD治疗期间Ig水平下降与CS暴露有很强的联系.
- CS对Ig水平的持续影响是未来涉及Ig测量的MS研究的重要混变量.
相关概念视频
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
186
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
186
Autoimmune Disorders
481
Autoimmune diseases are a group of disorders in which the body's immune system mistakenly attacks its own cells, tissues, and organs. This results from an overactive immune response against substances and tissues normally present in the body. Let's delve into the concept and mechanism of autoimmune diseases from an immune system point of view, explore different causes and examples of such diseases, and discuss potential solutions.
Concept and Mechanism of Autoimmune Diseases
The immune...
Concept and Mechanism of Autoimmune Diseases
The immune...
481
Immunodeficiency Diseases
970
Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency...
There are three main causes of immunodeficiency...
970
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
144
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2...
144
T Cell Types and Functions
1.1K
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
1.1K
Myasthenia Gravis: Overview and Treatment
1.6K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
1.6K


